B-FLEXION Life Sciences to Acquire Remaining 57% Interest in Radius Health
Transaction follows three years of accelerated growth and successful operations under B‑FLEXION and Patient Square’s ownership. BOSTON, Jan. 12, 2026 /PRNewswire/... Read more.
Navigate360 Ends the Era Disconnected Panic Buttons & K-12 Emergency Response
Integrating wearable panic buttons with the industry’s most advanced emergency preparedness, response, and reunification platform, Navigate360 transforms a... Read more.
New Book Reframes Innovation Around Integrity, Collaboration, and Human-Centered Design
Author challenges profit-first thinking and offers leaders a new operating logic for sustainable growth AUSTIN, Texas, Jan. 12, 2026 /PRNewswire/ — As institutions... Read more.
WuXi Biologics Launches Industry-Leading Digital Twin Platform PatroLab™ Designed to Transform Bioprocessing and Manufacturing
SHANGHAI, Jan. 12, 2026 /PRNewswire/ — WuXi Biologics (2269.HK), a leading global Contract Research, Development, and Manufacturing Organization (CRDMO), today... Read more.
Rigel Provides Business Update and 2026 Outlook
Preliminary fourth quarter 2025 total revenue of approximately $69.8 million, including net product sales of $65.4 million and contract revenues of $4.4 million... Read more.
PENGUIN AI LAUNCHES HCC CODING & RISK ADJUSTMENT SOLUTION AS SNOWFLAKE NATIVE APP ON SNOWFLAKE MARKETPLACE
Joint customers can improve coding accuracy, strengthen compliant submissions, and strengthen RAF integrity with Penguin Ai’s HCC Coding & Risk Adjustment... Read more.
Kaffea-X Launches a Digital Marketplace for Specialty Green Coffee, Introducing Standardized Pricing and Escrow-Based Trade Security
SHORT HILLS, N.J., Jan. 12, 2026 /PRNewswire/ — Kaffea-X today announced the launch of its digital marketplace for specialty green coffee, designed to address... Read more.
CARsgen and Dispatch Bio Announce Clinical Collaboration to Evaluate Flare Platform and Zevor-cel in Solid Tumors
SHANGHAI, PHILADELPHIA and SAN FRANCISCO, Jan. 12, 2026 /PRNewswire/ — CARsgen Therapeutics Holdings Limited (Stock Code: 2171.HK), a company focused on developing... Read more.
PIERRE FABRE PHARMACEUTICALS STATEMENT REGARDING RECEIPT OF COMPLETE RESPONSE LETTER FOR TABELECLEUCEL BIOLOGICS LICENSE APPLICATION FROM THE U.S. FOOD AND DRUG ADMINISTRATION
SECAUCUS, N.J., Jan. 12, 2026 /PRNewswire/ — On January 9, 2026, Pierre Fabre Pharmaceuticals, Inc. received a Complete Response Letter (CRL) from the U.S.... Read more.
Community Memorial Hospital Chooses Oracle Health to Enhance Patient Care and Power Operational Excellence
Will use Oracle Health Clinical AI Agent to help doctors spend more time with patients Plans to replace disparate legacy systems with Oracle Health Foundation EHR... Read more.